Quarterly trends in oral anticoagulant prescriptions for atrial fibrillation, from the fourth quarter of 2010 (2010Q4) to the first quarter of 2017 (2017Q1)
Y-axis refers to the percentage of incident OAC users prescribed a specific OAC.
OAC indicates oral anticoagulant; NOAC, non-vitamin K antagonist oral anticoagulants, including dabigatran, rivaroxaban, and apixaban.